The U.S. The Department of Health and Human Services has canceled a contract with...

Dive Brief: Veru’s muscle-preserving obesity drug enobosarm, when combined with Novo Nordisk’s Wegovy, may...

Dive Brief: Cancer drugmaker iTeos Therapeutics said Wednesday it plans to wind down operations...

Eli Lilly is wagering up to $1 billion on a private biotechnology company developing...

Dive Brief: The Food and Drug Administration on Thursday recommended COVID-19 vaccine manufacturers tailor their...

As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the...

Dive Brief: After discussions with the Food and Drug Administration, Moderna on Wednesday said...

Today, a brief rundown of news involving Pfizer and Sarepta Therapeutics, as well as...

Novo Nordisk is ramping up its war on compounders making versions of its top-selling...

The House passed Republicans’ “big, beautiful bill” on Thursday in a razor-thin 215-214 vote, sending the...

Sanofi has agreed to spend $470 million to take control of a young biotechnology...

For decades now, doctors tasked with diagnosing breast cancer have peered into microscopes and...

Advisers to the Food and Drug Administration have recommended COVID-19 vaccine makers continue to...

A combination of Roche’s cancer immunotherapy Tecentriq and a drug called Zepzelca helped extend...

Expert advisers to the Food and Drug Administration on Tuesday backed Johnson & Johnson’s...

ReproNovo, a biotechnology company specializing in reproductive medicine, has raised $65 million to advance...

Today, a brief rundown of news involving Tourmaline Bio, Schrödinger and Beckley Psytech, as...

The Food and Drug Administration is changing how it reviews new COVID-19 vaccines, setting...

Novavax has at last gained full Food and Drug Administration approval for its COVID-19...

Prime Medicine will lay off one-quarter of its workforce and deprioritize its clinical-stage program...

Retail and specialty-lite brand teams are facing a paradox – they’re drowning in data...

AbbVie is staking hundreds of millions of dollars on RNA interference, agreeing on Wednesday...

Dive Brief: Sanofi plans to invest at least $20 billion in the U.S. over...

Novo Nordisk CEO Lars Fruergaard Jørgensen, who led the Danish drugmaker to new heights...

Today, a brief rundown of news involving Amgen and Regeneron, as well as updates...

BioMarin Pharmaceutical has agreed to spend $270 million to take control of a Boston-based...

Connecticut-based Biohaven has been developing what it hopes will be the first medicine for...

A group of scientists successfully made a bespoke gene editing medicine for a critically...

Dive Brief: British drugmaker GSK has agreed to pay privately held Boston Pharmaceuticals $1.2...

Dive Brief: Novo Nordisk on Wednesday said it will collaborate with biotechnology startup Septerna...

President Donald Trump’s declaration Monday that the Department of Health and Human Services will...

The women’s health field has a long way to go addressing persistent deficits in...

The Trump administration is resurrecting a controversial policy that aims to tamp down some...

Safety concerns have spurred the Food and Drug Administration and Centers for Disease Control...

The number of registered US clinical trials has almost tripled in the last decade,...

Emerging biopharma companies are now taking the lead on drug development, with smaller and...

Scientists long believed the human genome consisted mostly of useless DNA. These sequences, after...

To hear Vinay Prasad tell it, U.S. healthcare is too ready to intervene unnecessarily,...

Dive Brief: Gilead on Wednesday became the latest U.S. drugmaker to pledge new investments...

Today, a brief rundown of news involving Eli Lilly and Valneva, as well as...

Four biotechnology companies are laying off staff in the latest examples of cutbacks in...

Pittsburgh-based pharmaceutical firm Viatris on Thursday said a pain drug it’s been developing succeeded...

Dive Brief: While revenue and profit rose year-over-year during the first quarter at Novo...

A panel of Food and Drug Adminsitration advisers will meet May 22 to discuss...

Shares in more than a dozen gene and cell therapy developers tumbled by double...

Vinay Prasad, a prolific academic and longtime critic of U.S. drug policies, was named...

AI drug discovery specialist Recursion Pharmaceuticals is shelving three of its most advanced drug...

Dive Brief: Shares in PTC Therapeutics fell by double-digits Monday morning as investors parsed...

Dive Brief: Madrigal Pharmaceuticals said its pioneering medicine for a common liver disease brought...

AstraZeneca on Tuesday confirmed it has closed down its neuroscience research group to direct...

Today, a brief rundown of news involving Arvinas and Biogen, as well as updates...

Dive Brief: CVS Health’s pharmacy benefit manager Caremark reached an agreement with Danish drugmaker...

Today, a brief rundown of news involving Cytokinetics and AstraZeneca, as well as updates...

Dive Brief: Amgen on Thursday said its just-launched biosimilar of Johnson & Johnson’s autoimmune...

The Food and Drug Administration has asked Moderna for additional data before it will...

The threat of tariffs on pharmaceuticals imported to the U.S. hasn’t yet pushed drugmakers...

The Food and Drug Administration on Wednesday approved an antibody drug that developer Johnson...

Novartis will pay $800 million upfront to acquire Regulus Therapeutics, a San Diego biotechnology...

A shareholder of immune drug developer Acelyin believes the company is better off shutting...

Pfizer will maintain its 2025 financial forecasts for now, but warned Tuesday it can’t...

Dive Brief: Merck KGaA has agreed to buy biotechnology company SpringWorks Therapeutics, announcing Monday...

Novavax claims it can surmount the latest regulatory hurdle hindering its quest to win...

Venture capitalists have been scouring the globe in search of better immunology drugs. Biotech...

Dive Brief: Sanofi’s first-quarter sales and profit exceeded analyst expectations, but the company held...

Caribou Biosciences is laying off about a third of its staff and stopping work...

Today, a brief rundown of news involving Merck and Vanda Pharmaceuticals, as well as...

Dive Brief: Gilead Sciences on Thursday reported $6.7 billion in revenue in the first...

Biohaven lost close to $400 million in market value Friday on news that the...

Dive Brief: Merck & Co. “absorbed” $200 million in addition expenses related to U.S....

A new, closely watched schizophrenia medication from Bristol Myers Squibb sold well in its...

A brain drug at the center of a recent $14 billion acquisition has failed...

Dive Brief: Veraxa Biotech, a cancer therapy developer backed by Swiss incubator Xlife Sciences,...

The Trump administration is radically revising the scale and scope of the federal health...

Dive Brief: Roche is the latest drugmaking planning to expand drug production in the...

A two-drug regimen involving AstraZeneca and Daiichi Sankyo’s Enhertu topped standard therapy in a...

Dive Brief: Novo Nordisk asked the Food and Drug Administration to approve a pill...

The Food and Drug Administration’s attempt to increase regulatory scrutiny over laboratory developed tests...

A draft budget document shows the Trump administration’s plan to slash funding to the...

Today, a brief rundown of news involving GSK and Bristol Myers Squibb, as well...

The Food and Drug Administration will aim to limit the participation of industry experts...

A British investment fund has launched with plans to extract tens of billions of...

The Food and Drug Administration on Friday approved a new use for Sanofi and...

Dive Brief: French drugmaker Sanofi agreed to pay $125 million to startup Earendil Labs...

Dive Brief: Eli Lilly’s weight loss pill orforglipron succeeded in a Phase 3 clinical...

Bluebird bio is still waiting on a binding takeover bid from Ayrmid Ltd., three...

The most effective drug for Parkinson’s disease hasn’t changed in 50 years. But fresh...

The mass layoffs that swept the U.S. health department this month were chaotic and...

Johnson & Johnson is confident it can manage the impact of tariffs on its...

The Trump administration is investigating the effects of pharmaceutical imports on national security, disclosing...

Dive Brief: Pfizer is scrapping another obesity pill, announcing Monday it will stop testing...

AdvaMed and nine other healthcare organizations continue to pressure the White House to exempt...

Dive Brief: President Trump on Tuesday said he’s planning soon to announce “a major...

Dive Brief: Tempest Therapeutics is seeking a buyer or partner, saying Wednesday it has...

Dive Brief: The Food and Drug Administration aims to phase out animal toxicology testing...

Today, a brief rundown of news involving Amgen and the Parker Institute, as well...

Dive Brief: Novartis will substantially expand its U.S. footprint, announcing Thursday plans to spend...

Dive Brief: Biotech executives and venture capital investors are banding together to press Congress...

The U.S. is pausing most country-specific tariffs for 90 days while raising duties on...

Today, a brief rundown of news involving Ferring Pharmaceuticals and Solu Therapeutics, as well...

Dive Brief: The biotechnology company Rallybio is discontinuing its lead candidate for a rare...

The U.S. risks losing a once-decisive edge over China in biotechnology unless the federal...

Oncology drugmaker Tango Therapeutics has cut about 20% of its staff, following a year...

GSK is betting potentially billions of dollars that a smaller drug company’s technology can...

Dive Brief: Artis BioSolutions emerged from stealth Wednesday, announcing that it has acquired Landmark...

Biotechnology company funding rounds remain larger than they were in 2022 and 2023, in...

Mehmet Oz, a physician and TV personality, was confirmed Thursday by the U.S. Senate...

The world’s largest pharmaceutical companies mostly steered clear of billion-dollar acquisitions in the early...

Today, a brief rundown of news involving Sarepta Therapeutics, Novartis and Allakos, as well...

Healthcare industry groups and analysts are reeling after President Donald Trump unveiled a sweeping...

The Food and Drug Administration review deadline for Novavax’s COVID-19 vaccine has come and...

Dive Brief: Roche has stopped enrolling and treating patients in three studies of the...

The U.S. will implement a universal baseline tariff of 10%, effective April 5, along...

Today, a brief rundown of news involving Eisai, Biogen and Sanofi, as well as...

A Texas federal court on Monday struck down the Food and Drug Administration’s new...

Employees across the Department of Health and Human Services began receiving layoff notices Tuesday,...

Over the past decade, several dozen cell and gene therapies have reached market in...

Shares of several prominent vaccine makers fell Monday morning after the resignation late Friday...

Just before 9 a.m. Thursday in Washington, D.C, the Department of Health and Human...

Dive Brief: Novartis’ radiopharmaceutical drug Pluvicto can now be used much more widely to...

Peter Marks, the Food and Drug Administration’s top vaccine official, abruptly resigned from the...

Bluebird bio on Friday received a new buyout offer that surpasses a take-private bid...

The Food and Drug Administration approved on Friday a new type of medicine for...

Eli Lilly plans to appeal a verdict from key drug regulators who say the...

The leading eye-care company Alcon on Wednesday said it has acquired a majority stake...

Nkarta is laying off a third of its workforce, and more than half its...

The Food and Drug Administration on Wednesday approved the first treatment for the insatiable...

The U.S. Senate on Tuesday confirmed Johns Hopkins University surgeon Martin Makary to be...

Character Biosciences, a biotechnology startup developing treatments for vision loss, said Tuesday it raised...

Dive Brief: Merck & Co. has entered a competitive race for a new type...

Verve Therapeutics is expanding a gene editing trial for a cholesterol and heart disease...

Dive Brief: Novo Nordisk is expanding its pipeline of obesity medicines, announcing Monday it...

On Wednesday, Novartis gave a more detailed look at long-awaited clinical data that the...

Dive Brief: Johnson & Johnson is planning a major U.S. expansion, announcing Friday it...

Dive Brief: Optum Rx is shifting to a new pharmacy reimbursement model that should...

Today, a brief rundown of news involving AstraZeneca and Novartis, as well as updates...

A postponed meeting of vaccine advisers to the Centers for Disease Control and Prevention...

Alynlam Pharmaceuticals will sell its drug for a life-threatening heart disease at almost double...

The Food and Drug Administration on Thursday approved an Alnylam Pharmaceuticals medicine for a...

Dive Brief: Sanofi agreed to pay $600 million for a therapy in early human...

Dive Brief: Optum Rx is moving to eliminate prior authorization requirements for dozens of...

Dive Brief: Cell therapy developer Cargo Therapeutics is laying off 90% of its workforce...

Dive Brief: Prime Medicine will test its gene editing technology as treatment for a...

A young man with Duchenne muscular dystrophy has died following treatment with Sarepta Therapeutics’...

Japan-based Taiho Pharmaceuticals on Monday said it will acquire Switzerland’s Araris Biotech and its...

AstraZeneca is bolstering its cell therapy capabilities, agreeing on Monday to pay up to...

The Inflation Reduction Act seems to be sticking around under the new Trump administration,...

Dive Brief: Ionis Pharmaceuticals is licensing out another experimental medicine, entering an agreement with...

Today, a brief rundown of news involving Martin Makary, as well as updates from...

The Food and Drug Administration on Thursday recommended to influenza vaccine manufacturers which virus...

Dive Brief: Mallinckrodt and Endo Pharmaceuticals, which have struggled through bankruptcies related to opioid...

Gene therapy specialist MeiraGTx is spinning some of its experimental medicines for the central...

Today, a brief rundown of news involving Harbour BioMed and Gilead Sciences, as well...

Dive Brief: Roche has raised its bet on obesity, agreeing to pay Zealand Pharma...

Merck & Co. on Tuesday opened a new vaccine manufacturing plant in Durham, North...

Dive Brief: Viking Therapeutics is secure production capacity for its experimental obesity drug, announcing...

Dive Brief: Novo Nordisk’s experimental drug CagriSema helped people who are overweight or obese...

Preliminary results from a small clinical trial suggest that a cutting-edge genetic medicine developed...

Cell and gene therapy innovators are after “a gene and a dream.” Those are...

Marty Makary, the Johns Hopkins surgeon who President Donald Trump chose to lead the...

Dive Brief: Walgreens has entered into a definitive agreement to be acquired by private...

Jeb Keiper, the longtime head of Nimbus Therapeutics, is stepping down in a planned...

This week has brought enough announcements and updates to fill a third news roundup....

Johnson & Johnson is terminating some research for an experimental drug that the company...

Marty Makary, President Donald Trump’s nominee to run the Food and Drug Administration, said...

Optum Rx, a pharmacy benefit manager owned by one of the country’s largest insurance companies,...

Dive Brief: Bayer CEO Bill Anderson is asking investors to bear with the German...

Jazz Pharmaceuticals is expanding its foothold in cancer drug research, announcing Wednesday it will...

Today, a brief rundown of news involving Acelyrin and Neumora Therapeutics, as well as...

European venture capital firm Sofinnova Partners has raised 1.2 billion euros, or nearly $1.3...

Merck & Co.’s cancer immunotherapy Keytruda is one of the pharmaceutical industry’s biggest successes....

Dive Brief: Callio Therapeutics on Monday launched with $187 million in Series A funding...

Eli Lilly will invest tens of billions more dollars in U.S. drug manufacturing in...

Today, a brief rundown of news involving Praxis Medicines and Bristol Myers Squibb, as...

BridgeBio Oncology Therapeutics, a cancer drug startup spun out of biotechnology company BridgeBio Pharma,...

Dive Brief: European drug reviewers have “reaffirmed” their positive view of Eisai and Biogen’s...

Dive Brief: Vertex Pharmaceuticals has pulled out of a planned four-year collaboration with Verve...

A meeting of Food and Drug Administration advisers to determine the composition of flu...

Today, a brief rundown of news involving AstraZeneca and Madrigal Pharmaceuticals, as well as...

Eight years ago, Eli Lilly CEO David Ricks stood in front of a red...

Eikon Therapeutics, a well-funded drug startup run by Merck & Co.’s former research chief, has...

Dive Brief: Drug compounders are suing the Food and Drug Administration again over obesity...

The biotechnology sector’s foundations rest on basic scientific research. Early experiments done in academic...

Many people who were fired from the Food and Drug Administration’s medical device center...

Early-phase clinical trials, including phase 1 and some phase 2a studies, serve as a...

Bluebird bio, a pioneering gene therapy developer that in recent years has struggled to...

Dive Brief: Weak demand for Pfizer’s hemophilia gene therapy Beqvez has led the pharmaceutical...

Today, a brief rundown of news involving Novo Nordisk, Acelyrin and Intra-Cellular Therapies, as...

The firing of possibly thousands of people working in U.S. health agencies this past...

An upcoming meeting of vaccine advisers to the Centers for Disease Control and Prevention...

Today, a brief rundown of news involving Sanofi and Supernus Pharmaceuticals, as well as...

Advamed CEO Scott Whitaker warned the Department of Health and Human Services that job...

Dive Brief: An experimental Duchenne muscular dystrophy gene therapy from Solid Biosciences showed potential...

Dive Brief: Through a new deal, Biogen has bought access to a potentially first-of-its-kind...

The Financial Burden of Care Navigating healthcare is challenging for most individuals and families,...

The Trump administration has directed federal agencies to “undertake plans for large-scale reductions in...

Dive Brief: Biogen is set to receive as much as $250 million in funding...

Scientists believe GLP-1 drugs like Novo Nordisk’s Ozempic help people with obesity lose weight...

Dive Brief: Sanofi and Johnson & Johnson are ending a Phase 3 study of...

Robert F. Kennedy Jr., a prominent vaccine critic who President Donald Trump has directed...

Drug development is a notoriously expensive business. Discovering, testing and advancing a medicine can...